Marinus Pharmaceuticals Inc (MRNS)
1.34
-0.02
(-1.47%)
USD |
NASDAQ |
Jun 26, 09:48
Marinus Pharmaceuticals Revenue (Annual): 30.99M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 30.99M |
December 31, 2022 | 25.48M |
December 31, 2021 | 15.34M |
December 31, 2020 | 1.718M |
December 31, 2019 | |
December 31, 2018 |
Date | Value |
---|---|
December 31, 2017 | |
December 31, 2016 | |
December 31, 2015 | |
December 31, 2014 | |
December 31, 2013 | |
December 31, 2012 | 0.10M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
1.718M
Minimum
2020
30.99M
Maximum
2023
18.38M
Average
20.41M
Median
Revenue (Annual) Benchmarks
Arcutis Biotherapeutics Inc | 59.61M |
Heron Therapeutics Inc | 127.04M |
Pfizer Inc | 58.50B |
Gritstone Bio Inc | 1.331M |
Actinium Pharmaceuticals Inc | 0.081M |